Investor Science Conference Call

Taking our science to the European Respiratory Society 2016: Benralizumab Phase III results in uncontrolled severe asthma

AstraZeneca will be hosting an Investor science conference call from the European Respiratory Society, London on 7 September 2016. An audio webcast will take place at 14:00 BST (15:00 CEST, 09:00 EDST). The presentation will be followed by a question and answer (Q&A) session.
 
The presentation for the conference call is available to download here. If you would like to pre-register for the webcast please click here
 
Conference call
If you wish to participate in the Q&A session, please dial in five minutes prior to the start time using the numbers and conference code below:
 
Sweden Local:  +46(0)8 5352 6408
Sweden Free phone: 0200 883 440
UK Local: +44(0)20 3427 1914
UK Free phone: 0800 279 4841
US Local: +1646 254 3388
US Free phone: 1877 280 2342
 
Conference code: 9090719
 
Conference call - listen only
If you wish to listen to the audio only, please dial in five minutes prior to the start time using the numbers and conference code below:
 
Sweden Local:  +46(0)8 5065 3938
UK Local: +44(0)20 3427 1912
UK Free phone: 0800 279 4992
US Local: +1646 254 3363
Conference code: 9090719
 
A replay and a transcript from the audio webcast will be made available shortly after the conclusion of the call here.

ERS Investor science conference call presentation